Human cytochromes P450: evolution and cDNA-directed expression.
暂无分享,去创建一个
[1] M. J. Coon,et al. Oxygen activation by cytochrome P-450. , 1980, Annual review of biochemistry.
[2] T. Sugimura,et al. Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. , 1985, Mutation research.
[3] P. Watkins,et al. Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat. , 1986, Molecular pharmacology.
[4] D. Nelson,et al. Evolution of cytochrome P-450 proteins. , 1987, Molecular biology and evolution.
[5] F. Guengerich,et al. Metabolism of N-nitrosodialkylamines by human liver microsomes. , 1988, Cancer research.
[6] O. Mcbride,et al. Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. , 1988, Biochemistry.
[7] F. Gonzalez,et al. The molecular biology of cytochrome P450s. , 1988, Pharmacological reviews.
[8] T. Aoyama,et al. cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. , 1989, Biochemistry.
[9] O. Mcbride,et al. Identification of a new P450 expressed in human lung: complete cDNA sequence, cDNA-directed expression, and chromosome mapping. , 1989, Biochemistry.
[10] P. Srivastava,et al. Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae. , 1989, Biochemistry.
[11] U. Thorgeirsson,et al. Induction of hepatocellular carcinoma in nonhuman primates by the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline. , 1994, Environmental health perspectives.
[12] F. Gonzalez,et al. Human cDNA‐Expressed Cytochrome P450 IA2: Mutagen Activation and Substrate Specificity , 1989, Molecular carcinogenesis.
[13] T. Aoyama,et al. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. , 1989, The Journal of biological chemistry.
[14] M. Sari,et al. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae. , 1990, Biochemistry.
[15] D. Nebert,et al. Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation. , 1990, Trends in genetics : TIG.
[16] F. Gonzalez,et al. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. , 1990, Biochemistry.
[17] A. Hinnen,et al. Constitutive and inducible expression of human cytochrome P450IA1 in yeast Saccharomyces cerevisiae: an alternative enzyme source for in vitro studies. , 1990, Biochemical and biophysical research communications.
[18] M. P. Arlotto,et al. Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. , 1990, Carcinogenesis.
[19] T. Aoyama,et al. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Relling,et al. Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. , 1990, The Journal of pharmacology and experimental therapeutics.
[21] R. Tyndale,et al. Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype. , 1991, Pharmacogenetics.
[22] F. Gonzalez,et al. The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. , 1991, Carcinogenesis.
[23] U. Meyer,et al. Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA. , 1991, Molecular pharmacology.
[24] D W Nebert,et al. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. , 1991, DNA and cell biology.
[25] P. Vineis,et al. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. , 1991, Pharmacogenetics.
[26] T. Shimada,et al. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. , 1991, Chemical research in toxicology.
[27] M. Romkes,et al. Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. , 1991, Biochemistry.